Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Allstate
ALL
$64.2B
| $46.9M | 0.02% |
430,025
-701,479
| -62% | -$79.6M |
|
777
CALL
Airbnb
ABNB
$110B
| $46.6M | 0.02% |
363,900
+339,000
| +1,361% | +$39.7M |
|
778
Dave & Buster's
PLAY
$357M
| $46.5M | 0.02% |
1,043,122
+704,425
| +208% | +$25.7M |
|
779
Owens Corning
OC
$11.7B
| $46.5M | 0.02% |
355,992
+263,944
| +287% | +$28.9M |
|
|
NTST
780
NETSTREIT Corp
NTST
$2.07B
| $46.4M | 0.02% |
2,599,071
+143,123
| +6% | +$2.57M |
|
781
PUT
O'Reilly Automotive
ORLY
$72.1B
| $46.4M | 0.02% |
729,000
-70,500
| -9% | -$4.31M |
|
|
BKI
782
DELISTED
Black Knight, Inc. Common Stock
BKI
| $46.4M | 0.02% |
776,608
+452,749
| +140% | +$25.4M |
|
|
WRK
783
DELISTED
WestRock Company
WRK
| $46.3M | 0.02% |
1,593,509
-1,090,516
| -41% | -$31.6M |
|
784
Ciena
CIEN
$56B
| $46.3M | 0.02% |
1,089,307
+276,750
| +34% | +$12.6M |
|
785
PUT
TransDigm Group
TDG
$66.4B
| $46.1M | 0.02% |
51,600
-16,000
| -24% | -$12.7M |
|
786
CALL
Thermo Fisher Scientific
TMO
$233B
| $46.1M | 0.02% |
88,300
+59,900
| +211% | +$32.3M |
|
787
Illinois Tool Works
ITW
$80.4B
| $46M | 0.02% |
183,965
+76,316
| +71% | +$17.9M |
|
|
788
CALL
Vertex Pharmaceuticals
VRTX
$139B
| $45.9M | 0.02% |
130,500
-10,900
| -8% | -$3.67M |
|
789
Idacorp
IDA
$7.94B
| $45.9M | 0.02% |
447,313
+169,592
| +61% | +$18.2M |
|
790
NOV
NOV
$7.28B
| $45.9M | 0.02% |
2,861,079
+838,364
| +41% | +$13.7M |
|
791
CRH
CRH
$63.2B
| $45.8M | 0.02% |
820,933
+669,025
| +440% | +$33.4M |
|
|
792
CALL
Linde
LIN
$225B
| $45.5M | 0.02% |
119,500
+11,300
| +10% | +$4.13M |
|
793
CALL
Ford
F
$57.5B
| $45.5M | 0.02% |
3,009,700
+98,800
| +3% | +$1.25M |
|
794
Sanofi
SNY
$110B
| $45.5M | 0.02% |
843,561
-1,442,543
| -63% | -$77.6M |
|
795
Brinker International
EAT
$10.6B
| $45.3M | 0.02% |
1,237,058
+701,651
| +131% | +$26.4M |
|
796
Lyft
LYFT
$6.61B
| $45.2M | 0.02% |
4,716,092
+363,823
| +8% | +$3.5M |
|
797
EOG Resources
EOG
$80.3B
| $45.2M | 0.02% |
394,964
+255,684
| +184% | +$29.2M |
|
798
CoStar Group
CSGP
$13.1B
| $45.1M | 0.02% |
506,712
+496,318
| +4,775% | +$38.3M |
|
799
CALL
Cardinal Health
CAH
$53.4B
| $45M | 0.02% |
476,100
+175,800
| +59% | +$14.8M |
|
800
PUT
Lam Research
LRCX
$393B
| $45M | 0.02% |
700,000
+44,000
| +7% | +$2.48M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.